Valence Advantage Life Sciences Fund II, L.P. is a venture capital fund based in New York, New York. According to its most recent Form D, filed Mar 14, 2013, it has sold $60,800,000 of interests to 11 investors since its first sale in Mar 2012. The filing does not set a minimum investment. It relies on the Section 3(c)(7) exclusion, so investors generally must be qualified purchasers. Related persons named in the filing include Valence Life Sciences GP II, LLC; Eric Roberts; A. Leheny.
- Total raised
- $60,800,000Cumulative sales reported on Form D
- Investors
- 11
- First sale
- Mar 30, 2012
- Minimum investment
- None set
- Who can invest
- Qualified purchasersSection 3(c)(7): generally $5M+ in investments
- Offering exemption
- Other exemption
- Key people and entities
- Valence Life Sciences GP II, LLC; Eric Roberts; A. Leheny
- Latest Form D
- Mar 14, 2013
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Questions about Valence Advantage Life Sciences Fund II, L.P.
What is the minimum investment for Valence Advantage Life Sciences Fund II, L.P.?
Valence Advantage Life Sciences Fund II, L.P.'s latest Form D, filed Mar 14, 2013, does not set a minimum investment. Managers can still require one in the offering documents.
Who can invest in Valence Advantage Life Sciences Fund II, L.P.?
Valence Advantage Life Sciences Fund II, L.P. is generally open only to qualified purchasers (generally individuals with at least $5 million in investments), because it relies on Section 3(c)(7).
How much has Valence Advantage Life Sciences Fund II, L.P. raised?
Valence Advantage Life Sciences Fund II, L.P. reports $60,800,000 sold from 11 investors on its Form D filed Mar 14, 2013. This is cumulative sales since the offering began, not current assets or performance.
Where is Valence Advantage Life Sciences Fund II, L.P. based?
Valence Advantage Life Sciences Fund II, L.P. is based in New York, New York.
When did Valence Advantage Life Sciences Fund II, L.P. launch?
Valence Advantage Life Sciences Fund II, L.P. reports its first sale in Mar 2012.
Size compared with every venture capital fund
Raised more than 94% of the 1,246 venture capital funds based in New York, and more than 97% of all 14,864 that report sales.